|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 405/12 | (2006.01) |
| A61P 11/00 | (2006.01) | ||
| A61K 31/4709 | (2006.01) |
| (11) | Number of the document | 3170818 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16198922.3 |
| Date of filing the European patent application | 2008-12-04 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-19 |
| (46) | Date of publication of the claims translation | 2020-05-25 |
| (30) | Number | Date | Country code |
| 12162 P | 2007-12-07 | US |
| (72) |
KESHAVARZ-SHOKRI, Ali, US
ZHANG, Beili, US
KRAWIEC, Mariusz, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kietos 3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il)ciklopropankarboksamido)-3-metilpiridin-2-il)benzoinės rūgšties formos |
| SOLID FORMS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID |
| Payment date | Validity (years) | Amount | |
| 2025-11-18 | 18 | 347.00 EUR |
| 2026-12-04 |